Skip to main content
. 2023 Mar 14;2023(3):CD006499. doi: 10.1002/14651858.CD006499.pub5

ChiCTR‐INR‐17013777.

Study name Clinical study of extraocular muscle injection of botulinum toxin A in children with concomitant strabismus
Methods Randomized parallel‐group controlled trial
Participants Inclusion criteria
  • Patients with concomitant strabismus who have surgical indications (with a horizontal inclination of more than 15 prism after complete dressing, some of which are worn for three months)

  • Age <1 8 years old

  • = 15 prism degrees and = 50 prism degrees in horizontal strabismus prism degree;

  • To cooperate with the examination of this study

  • Children's family members voluntarily sign informed consent


Exclusion criteria
  • With other ocular organic diseases

  • With ocular surgery history

  • Systemic dysplasia or combined with craniocerebral and nervous system diseases

  • Combined with vertical strabismus, A/V‐type strabismus or vertical strabismus

  • Combined with nystagmus

  • Cannot co‐operate with the required examination of this study

  • Children's family members refuse to sign informed consent

Interventions Intervention 1: Botulinum toxin A injection
Intervention 2: Operation
Outcomes Primary outcomes: treatment success rate after 6 months of treatment
Secondary outcomes: preoperative and postoperative prism degree; binocular vision function; complications
Starting date First enrollment: 1 January 2018
Contact information Dr Fu Jing: fu_jing@126.com
Notes